Skip to search boxSkip to navigationSkip to main content

Resistance to apoptosis is correlated with the reduced caspase-3 activation and enhanced expression of antiapoptotic proteins in human cervical multidrug-resistant cells

  • Zhihu Ding
    ,
  • Xiaolong Yang
    ,
  • Alan Pater
    ,
  • Shou-Ching Tang(corresponding author)
*Corresponding author for this work
  • Memorial University of Newfoundland
    ,
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

<p>Recent studies have indicated that induction of apoptosis is the primary cytotoxic mechanism of most cancer chemotherapeutic agents, and abnormalities in the control of apoptosis can affect the sensitivity of malignant cells to multiple drugs. Here, we treated cells with cisplatin and other apoptotic stimuli and found that multidrug-resistant (MDR) endocervical HEN-16-2/CDDP cells, compared with drug-sensitive parental cells, were significantly more resistant to apoptosis and exhibited decreased proteolytic activation of caspase-3. The latter was further demonstrated by decreased cleavage of its substrate poly(ADP-ribose) polymerase (PARP). Further, Western blot analysis showed that MDR HEN-16-2/CDDP cells had significantly higher levels of the apoptosis-inhibiting proteins BAG-1 p50 and p33 isoforms and Bcl-X(L). This study provided the first evidence that overexpression of antiapoptotic BAG-1 p50 and p33 and Bcl-X(L) may cause resistance to apoptosis through reduction of caspase-3 activity in human cervical cells having an MDR phenotype. (C) 2000 Academic Press.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 415-420 (6 pages)

Journal (Volume, Issue Number)

Biochemical and Biophysical Research Communications (Volume 270, Issue 2)

Publication milestones

  • Published - 04/13/2000

Publication status

Published - 04/13/2000

ISSN

0006-291X

Publication IDs

  • Scopus: 0034643253
  • PubMed: 10753639

Publication metrics

Metrics

SciVal
citations
66
SciVal
FWCI
1.55
SciVal
Author count
4
SciVal
Paper percentile
88
Scopus
citations
Fractional count
1
Fractional count
0.25
Fractional count
3
Fractional count
0.75
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
22
Citation count
81

Funding Details

We thank Mr. G. Chernenko and Ms. Y. Hao for excellent technical assistance. The investigation was supported in part by a grant from the National Cancer Institute of Canada with funds from the Canadian Cancer Society and grants from the Medical Research Council of Canada.
FundersFunding numbers
National Cancer Institute of Canada
-
Canadian Cancer Society
-
MRC
-